Anti-CD3 x Anti-FcRH5 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD3 and anti-FcRH5 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can retarget T cells to tumor cells. It is designed for the research of Multiple myeloma (MM); B cell malignancies therapy.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY